The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.
Johnson and Johnson has posted stronger than expected Q3 results, helped by it riding out biosimilar challenges and strong growth from Stelara and a host of cancer drugs.